Healthcare / Health Information ServicesStockholm
$35.32
+0.30 (+0.86%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $89.7M · quality 66.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
52/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.8B
P/E
34.3x
↑EV/EBITDA
6.5x
↓ROE
1.6%
↑Gross Margin
66.3%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.3%
FCF CAGR
-31.5%
FCF margin
3.1%
FCF / Net income
0.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $992.3M · net income $66.8M · FCF $30.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $992.3M | $992.3M | $884.1M | $882.9M | $802.5M |
| Net Income | $66.8M | $66.8M | $131.6M | $234.0M | $188.0M |
| EBITDA | $189.8M | $189.8M | $224.3M | $324.5M | $261.1M |
| EPS | 1.31 | 1.31 | 2.58 | 4.59 | 3.69 |
| Gross Margin | 66.3% | 66.3% | 67.6% | 69.4% | 66.2% |
| Operating Margin | 6.9% | 6.9% | 16.3% | 21.4% | 20.3% |
| Net Margin | 6.7% | 6.7% | 14.9% | 26.5% | 23.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Current Ratio | 4.47 | 4.47 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $30.5M | $30.5M | $89.7M | $194.2M | $94.9M |
| Returns | |||||
| ROE | 1.6% | 1.6% | 2.7% | 5.4% | 4.4% |
| Valuation | |||||
| P/E | 34.29 | 34.29 | 60.08 | 36.91 | 43.20 |
| EV/EBITDA | 6.55 | 6.55 | 31.20 | 24.76 | 29.48 |
| P/B | 0.42 | 0.42 | 1.64 | 1.99 | 1.92 |
| Growth & Yield | |||||
| Revenue Growth | 12.2% | 12.2% | 0.1% | 10.0% | — |
| EPS Growth | -49.2% | -49.2% | -43.8% | 24.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
33.7%
EPS terminal req.
$3.13
Spread vs growth
-83.0%
5Y implied EPS CAGR
23.7%
EPS terminal req.
$3.79
Spread vs growth
-72.9%
10Y implied EPS CAGR
16.6%
EPS terminal req.
$6.11
Spread vs growth
-65.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-75.5%
Start / end P/E
56.0x → 27.0x
EPS bridge
2.58 → 1.31
Residual
+25.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.